Boiling and ready to burst as ACADIA Pharmaceuticals Inc. (ACAD) last month performance was 14.87%

At the end of the latest market close, ACADIA Pharmaceuticals Inc. (ACAD) was valued at $46.36. In that particular session, Stock kicked-off at the price of $45.90 while reaching the peak value of $47.75 and lowest value recorded on the day was $45.32. The stock current value is $46.42.

Recently in News on October 26, 2020, Acadia Pharmaceuticals to Present New Scientific Data on Pimavanserin in Neurodegenerative Diseases at the 13th Clinical Trials on Alzheimer’s Disease (CTAD) Conference. Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that scientific presentations highlighting new analyses of pimavanserin clinical study data in dementia-related psychosis and neurodegenerative diseases will be shared at the 13th Clinical Trials on Alzheimer’s Disease Conference (CTAD), being held virtually November 4-7, 2020. You can read further details here

My Next COVID-19 Stock Alert Poised For Triple Digit Moves

Get Ready for my next COVID-19 stock idea. I have been very fortunate in discovering biotech, therapeutic and diagnostic companies within the COVID-19 space, before wall street catches on. Our goal for our members is to get our Alert’s first before the crowd.    

>> Sign Up Now to Get Name & Ticker Symbol of Next Triple-Digit Gainer <<


ACADIA Pharmaceuticals Inc. had a pretty favorable run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $58.72 on 07/07/20, with the lowest value was $30.02 for the same time period, recorded on 03/16/20.

ACADIA Pharmaceuticals Inc. (ACAD) full year performance was 9.84%

Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, ACADIA Pharmaceuticals Inc. shares are logging -20.95% during the 52-week period from high price, and 54.63% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $30.02 and $58.72.

The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 2098585 for the day, which was evidently higher, when compared to the average daily volumes of the shares.

When it comes to the year-to-date metrics, the ACADIA Pharmaceuticals Inc. (ACAD) recorded performance in the market was 8.51%, having the revenues showcasing 9.25% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 7.21B, as it employees total of 570 workers.

The Analysts eye on ACADIA Pharmaceuticals Inc. (ACAD)

According to the data provided on, the moving average of the company in the 100-day period was set at 44.01, with a change in the price was noted -0.39. In a similar fashion, ACADIA Pharmaceuticals Inc. posted a movement of -0.83% for the period of last 100 days, recording 1,564,749 in trading volumes.

Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for ACAD is recording 0.00 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.00.

Technical rundown of ACADIA Pharmaceuticals Inc. (ACAD)

Raw Stochastic average of ACADIA Pharmaceuticals Inc. in the period of last 50 days is set at 88.36%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 81.97%. In the last 20 days, the company’s Stochastic %K was 88.19% and its Stochastic %D was recorded 84.64%.

Considering, the past performance of ACADIA Pharmaceuticals Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 8.51%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -3.91%, alongside a boost of 9.84% for the period of the last 12 months. The shares increased approximately by 13.11% in the 7-day charts and went down by 14.87% in the period of the last 30 days. Common stock shares were driven by 9.25% during last recorded quarter.

Get The Best Stocks To Trade Every Day!

Join now to get the pre-market morning brief 100% free